Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01062360Phase 3Completed
Phase 3, randomised, double-blind trial of aspirin and pseudoephedrine in common cold and pharyngitis (4 arms), sponsored by Bayer. Primary endpoints: Area Under the Curve for Nasal Congestion Score at 2 hours and Sum of Pain Intensity Difference at 2 hours. Started Dec 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01062360.